MedTech Acquisition Corp Performance
| MTACDelisted Stock | USD 10.55 0.03 0.28% |
The company secures a Beta (Market Risk) of -0.15, which conveys not very significant fluctuations relative to the market. As returns on the market increase, returns on owning MedTech Acquisition are expected to decrease at a much lower rate. During the bear market, MedTech Acquisition is likely to outperform the market. MedTech Acquisition Corp right now secures a risk of 0.0%. Please verify MedTech Acquisition Corp maximum drawdown, skewness, and the relationship between the total risk alpha and downside variance , to decide if MedTech Acquisition Corp will be following its current price movements.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days MedTech Acquisition Corp has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound basic indicators, MedTech Acquisition is not utilizing all of its potentials. The current stock price tumult, may contribute to shorter-term losses for the shareholders. ...more
| Begin Period Cash Flow | 200.9 K | |
| Total Cashflows From Investing Activities | 233.2 M |
MedTech |
MedTech Acquisition Relative Risk vs. Return Landscape
If you would invest 1,055 in MedTech Acquisition Corp on September 13, 2024 and sell it today you would earn a total of 0.00 from holding MedTech Acquisition Corp or generate 0.0% return on investment over 90 days. MedTech Acquisition Corp is currently does not generate positive expected returns and assumes 0.0% risk (volatility on return distribution) over the 90 days horizon. In different words, 0% of stocks are less volatile than MedTech, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
MedTech Acquisition Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for MedTech Acquisition's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as MedTech Acquisition Corp, and traders can use it to determine the average amount a MedTech Acquisition's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| MTAC |
Based on monthly moving average MedTech Acquisition is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of MedTech Acquisition by adding MedTech Acquisition to a well-diversified portfolio.
MedTech Acquisition Fundamentals Growth
MedTech Stock prices reflect investors' perceptions of the future prospects and financial health of MedTech Acquisition, and MedTech Acquisition fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on MedTech Stock performance.
| Return On Asset | -0.0193 | |||
| Current Valuation | 79.84 M | |||
| Shares Outstanding | 7.39 M | |||
| Price To Earning | 31.28 X | |||
| Price To Book | 1.31 X | |||
| EBITDA | (8.58 M) | |||
| Cash And Equivalents | 69.18 K | |||
| Total Debt | 2.37 M | |||
| Debt To Equity | 1.77 % | |||
| Book Value Per Share | (2.42) X | |||
| Cash Flow From Operations | (2.74 M) | |||
| Earnings Per Share | 0.05 X | |||
| Total Asset | 20.19 M | |||
| Retained Earnings | (13.27 M) | |||
About MedTech Acquisition Performance
By analyzing MedTech Acquisition's fundamental ratios, stakeholders can gain valuable insights into MedTech Acquisition's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if MedTech Acquisition has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if MedTech Acquisition has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
MedTech Acquisition Corporation does not have significant operations. The company was incorporated in 2020 and is based in Greenwich, Connecticut. Medtech Acquisition is traded on NASDAQ Exchange in the United States.Things to note about MedTech Acquisition Corp performance evaluation
Checking the ongoing alerts about MedTech Acquisition for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for MedTech Acquisition Corp help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| MedTech Acquisition is not yet fully synchronised with the market data | |
| MedTech Acquisition has a very high chance of going through financial distress in the upcoming years | |
| MedTech Acquisition Corp currently holds 2.37 M in liabilities with Debt to Equity (D/E) ratio of 1.77, which is about average as compared to similar companies. MedTech Acquisition Corp has a current ratio of 0.15, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Note, when we think about MedTech Acquisition's use of debt, we should always consider it together with its cash and equity. | |
| MedTech Acquisition Corp currently holds about 69.18 K in cash with (2.74 M) of positive cash flow from operations. | |
| Roughly 85.0% of MedTech Acquisition outstanding shares are owned by corporate insiders |
- Analyzing MedTech Acquisition's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether MedTech Acquisition's stock is overvalued or undervalued compared to its peers.
- Examining MedTech Acquisition's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating MedTech Acquisition's management team can have a significant impact on its success or failure. Reviewing the track record and experience of MedTech Acquisition's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of MedTech Acquisition's stock. These opinions can provide insight into MedTech Acquisition's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.
Other Consideration for investing in MedTech Stock
If you are still planning to invest in MedTech Acquisition Corp check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the MedTech Acquisition's history and understand the potential risks before investing.
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| CEOs Directory Screen CEOs from public companies around the world |